Motus GI Holdings, which is developing a medical device to assist with intraprocedural colonoscopy cleaning, announced terms for its IPO on Wednesday.
The Tirat Carmel, Israel-based company plans to raise $30 million by offering 4.3 million shares at a price range of $6 to $8. At the midpoint of the proposed range, Motus GI Holdings would command a fully diluted market value of $121 million.
Motus GI Holdings was founded in 2008 and plans to list on the Nasdaq under the symbol MOTS. Piper Jaffray and Oppenheimer & Co. are the joint bookrunners on the deal. It is expected to price during the week of February 5, 2018.
The article Medical device company Motus GI sets terms for $30 million IPO originally appeared on IPO investment manager Renaissance Capital’s web site renaissancecapital.com.
For more information, please visit: Motus GI & the “Pure-Vu system”